Peptide Capsomers for Monodisperse Nucleic Acid Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing nanostructures through self-assembly lack control over the dimensions and stability of one-dimensional objects, particularly for the delivery of nucleic acids, resulting in polydisperse and biologically inactive complexes.

Innovation Solution

The development of peptide segments with specific domains that self-assemble into capsomers, which can encapsulate charged compounds like DNA, forming monodisperse filamentous nanostructures with controlled dimensions and stability, utilizing a coiled-coil structure and a water-soluble polymer to enhance rigidity and biocompatibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If self-assembly methods are used to prepare one-dimensional nanostructures, then the formation of nanostructures is achieved, but control over dimensions and stability is lost resulting in polydisperse complexes

Engineering Contradiction:
Improvecontrol over dimensionsVSAvoidstability
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The self-assembling molecule is divided into distinct functional domains: a rigid rod domain for structural control and dimension definition, a coiled-coil domain for controlled oligomerization into capsomers, and a hydrophobic domain for nucleation control. This segmentation allows each domain to independently control specific aspects of assembly, achieving both dimensional precision and stability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent utilizes changes in physical and chemical parameters including pH, ionic strength, and temperature to control the self-assembly process. By adjusting these parameters, the system transitions from monomeric rods to oligomeric capsomers with controlled dimensions, achieving monodispersity and stability simultaneously.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If control of nucleation and kinetics is used for cylindrical micelles, then growth control is improved, but the nanostructures remain polydisperse due to supramolecular living polymerization

Engineering Contradiction:
Improvecontrol of nucleation and kineticsVSAvoidmonodispersity
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The rigid rod domain is pre-designed with specific length and stiffness parameters before assembly occurs. This preliminary structural definition sets the maximum dimension of the final capsomer, ensuring monodispersity. The coiled-coil domain is also pre-configured to form a specific number of oligomers, controlling the assembly stoichiometry in advance.

Inventive Principle:
Principle #10Preliminary action

3Ease of manufacture

If peptide amphiphiles form micrometer long nanofibers, then self-assembly occurs, but the structures lack controlled dimensions and are not suitable for nucleic acid delivery

Engineering Contradiction:
Improveself-assembly capabilityVSAvoidcontrolled dimensions
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent creates a composite self-assembling molecule combining rigid rod characteristics for dimensional control with coiled-coil characteristics for controlled oligomerization. This composite structure prevents uncontrolled fiber elongation while maintaining self-assembly capability, producing discrete capsomers with defined dimensions suitable for nucleic acid encapsulation.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the formation of highly homogeneous, stable nanostructures capable of efficient nucleic acid delivery, with controlled morphology and dimensions, suitable for gene and siRNA delivery, and exhibits electronic properties such as semiconductivity.

Implementation Method 1

In aqueous solution, coassembly was favored by hydrophobic collapse resulting in the formation of non-spherical core-shell supramolecular aggregates with controlled dimensions

Methodology Applied
Scientific EffectHydrophobic collapse: Hydrophobe

Implementation Method 2

the second domain comprises an amino acid sequence with a coiled-coil structure

Methodology Applied
Scientific EffectHydrogen bonding: Chemical Bonding

Implementation Method 3

the third domain comprises a water soluble polymer and is positioned at a second terminus of the second domain

Methodology Applied
Scientific EffectSolvation: Solvation

Data Source

PatentUS9650421B2Self-assembled nanostructures
Publication Date: 2017.05.16 NORTHWESTERN UNIV
  • US9650421B2 patent drawing
  • US9650421B2 patent drawing
  • US9650421B2 patent drawing

AI summary

The present disclosure is directed to the preparation of nanostructures by the encapsulation of a charged compound with individual self-assembled unit nano structures.